Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis Patients

被引:9
作者
Inaba, Masaaki [1 ]
Mori, Katsuhito [2 ]
Tsujimoto, Yoshihiro [3 ]
Yamada, Shinsuke [4 ]
Yamazaki, Yuko [4 ]
Emoto, Masanori [4 ,5 ]
Shoji, Tetsuo [5 ,6 ]
机构
[1] Ohno Mem Hosp, Renal Ctr, Nishi Ku, 1-26-10 Minami Horie, Osaka 5500015, Japan
[2] Osaka City Univ, Sch Med, Dept Nephrol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan
[3] Inoue Hosp, Div Internal Med, 16-17 Enoki Machi, Osaka 5640053, Japan
[4] Osaka City Univ, Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan
[5] Osaka City Univ, Grad Sch Med, Vasc Sci Ctr Translat Res, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan
[6] Osaka City Univ, Grad Sch Med, Dept Vasc Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5500015, Japan
关键词
low T3 syndrome; hemodialysis; sarcopenia; malnutrition; creatinine; POOR MUSCLE QUALITY; THYROID-FUNCTION; LOW TRIIODOTHYRONINE; CARDIOVASCULAR EVENTS; MORTALITY; DEIODINASE; DISEASE; STAGE; ILLNESS; MASS;
D O I
10.3390/nu13124537
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Purpose: Low T3 syndrome is defined by a fall in free triiodothyronine (FT3) in spite of normal serum thyroid-stimulating hormone (TSH) and often normal free thyroxin (FT4). A low FT3/FT4 ratio, a relevant marker for low T3 syndrome, is known as a risk of mortality in hemodialysis (HD) patients, as well as low muscle mass in the general population. Because of the local activation of T4 to FT3 in muscle tissue, we examined the association of FT3/FT4 ratio with serum creatinine, a marker of muscle mass and strength in HD patients to investigate the significance of muscle tissue in the development of low T3 syndrome in HD patients. Methods: This was a cross-sectional study derived from our prospective cohort study, named DREAM, of Japanese HD patients. After the exclusion of patients with treated and untreated thyroid dysfunction, 332 patients were analyzed in the study. Results: The serum FT4 and TSH of HD patients (n = 332) were 0.9 +/- 0.1 ng/dL. and 2.0 +/- 0.9 mu IU/mL, which were within the respective normal range, while serum FT3 was 2.2 +/- 0.3 pg/mL. As many as 101 out of 332 (30.4%) HD patients exhibited a serum FT3 less than the normal lower limit of 2.2 pg/mL. The serum FT3/FT4 ratio correlated significantly positively with serum creatinine, and inversely with serum log CRP and total cholesterol, while it exhibited a tendency towards positive correlation with serum albumin. Multiple regression analysis, which included serum creatinine, albumin, and log CRP, simultaneously, in addition to sex, age, diabetic kidney disease or not, log HD duration, body mass index, systolic blood pressure, and Kt/V, as independent variables, revealed an independent and significant positive association of serum creatinine, but not serum albumin or CRP, with the serum FT3/FT4 ratio. Conclusions: The present study demonstrated an independent and positive correlation of serum creatinine with the serum FT3/FT4 ratio in HD patients. The lack of association of the serum FT3/FT4 ratio with serum albumin and CRP suggested the presence of a creatinine-specific mechanism to associate with serum FT3/FT4 ratio. Because of the local activation of T4 to T3 at muscle tissue, a lower muscle mass may be causatively associated with low T3 syndrome.
引用
收藏
页数:9
相关论文
共 34 条
  • [1] Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells
    Ambrosio, Raffaele
    De Stefano, Maria Angela
    Di Girolamo, Daniela
    Salvatore, Domenico
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 459 (0C) : 79 - 83
  • [2] Thyroid Disease and the Cardiovascular System
    Danzi, Sara
    Klein, Irwin
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (02) : 517 - +
  • [3] The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration
    Dentice, Monica
    Marsili, Alessandro
    Ambrosio, Raffaele
    Guardiola, Ombretta
    Sibilio, Annarita
    Paik, Ji-Hye
    Minchiotti, Gabriella
    DePinho, Ronald A.
    Fenzi, Gianfranco
    Larsen, P. Reed
    Salvatore, Domenico
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (11) : 4021 - 4030
  • [4] Thyroid Function, Cardiovascular Events, and Mortality in Diabetic Hemodialysis Patients
    Drechsler, Christiane
    Schneider, Andreas
    Gutjahr-Lengsfeld, Lena
    Kroiss, Matthias
    Carrero, Juan Jesus
    Krane, Vera
    Allolio, Bruno
    Wanner, Christoph
    Fassnacht, Martin
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (06) : 988 - 996
  • [5] Triiodothyronine maintains cardiac transverse-tubule structure and function
    Gilani, Nimra
    Wang, Kaihao
    Muncan, Adam
    Peter, Jerrin
    An, Shimin
    Bhatti, Simran
    Pandya, Khushbu
    Zhang, Youhua
    Tang, Yi-Da
    Gerdes, A. Martin
    Stout, Randy F.
    Ojamaa, Kaie
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 160 : 1 - 14
  • [6] Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
    Ichii, Mitsuru
    Mori, Katsuhito
    Miyaoka, Daichi
    Sonoda, Mika
    Tsujimoto, Yoshihiro
    Nakatani, Shinya
    Shoji, Tetsuo
    Emoto, Masanori
    [J]. BMC NEPHROLOGY, 2021, 22 (01)
  • [7] Inaba M, 2010, CLIN NEPHROL, V74, P266
  • [8] Association of higher arterial ketone body ratio (acetoacetate/β-hydroxybutyrate) with relevant nutritional marker in hemodialysis patients
    Inaba, Masaaki
    Kumeda, Yasuro
    Yamada, Shinsuke
    Toi, Norikazu
    Hamai, Chie
    Noguchi, Koichi
    Yasuda, Eikichi
    Furumitsu, Yutaka
    Emoto, Masanori
    Ohno, Yoshiteru
    [J]. BMC NEPHROLOGY, 2020, 21 (01)
  • [9] Low free T3 to free T4 ratio was associated with low muscle mass and impaired physical performance in community-dwelling aged population
    Kong, S. H.
    Kim, J. H.
    Park, Y. J.
    Lee, J. H.
    Hong, A. R.
    Shin, C. S.
    Cho, N. H.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (03) : 525 - 531
  • [10] Larsen P.Reed., 2003, WILLIAMS TXB ENDOCRI, V10th